Serum omentin 1 level is associated with coronary artery disease and its severity in postmenopausal women

Angiology

Volumn 65, Issue 10, 2014, Pages 896-900

  Onur, Imran ^a   Oz, Fahrettin ^a   Yildiz, Sezai ^b   Oflaz, Huseyin ^a   Sigirci, Serhat ^b   Elitok, Ali ^a   Pilten, Saadet ^a   Karaayvaz, Ekrem Bilal ^a   Cizgici, Ahmet Y ^a   Kaya, Mehmet G ^c   Onur, Seda Tural ^b   Sahin, Irfan ^b   Dinckal, Hakan M ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b Bagcilar Education and Research Hospital   (Turkey)

^c Thoracic Surgery Teaching Hospital   (Turkey)

Author keywords

adipose tissue; coronary artery disease; inflammation; omentin 1; postmenopausal women; syntax score

Indexed keywords

ADIPOCYTOKINE; OMENTIN 1; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PROSPECTIVE STUDY; SYNTAX SCORE; BLOOD; CASE CONTROL STUDY; PREDICTIVE VALUE; RADIOGRAPHY; RISK FACTOR; SEVERITY OF ILLNESS INDEX;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; CYTOKINES; FEMALE; GPI-LINKED PROTEINS; HUMANS; LECTINS; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84908877626     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319713511322     Document Type: Article

References (19)

1. Heart Disease and Stroke Statistics - 2010 Update. A Report of the American Heart Association. Dallas, TX: Author ; 2010: 46-215.
2. Arslanian-Engoren C. Women's risk factors and screening for coronary heart disease. J Obstet Gynecol Neonatal Nurs. 2011 ; 40 (3). 337-346
3. Wang Z, Nakayama T. Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm. 2010 ; 2010: 535918
4. Pan H-Y, Guo L, Li Q. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract. 2010 ; 88 (1). 29-33
5. de Souza Batista CM, Yang RZ, Lee MJ, et al. Omentin plasma levels and gene expression are decreased in obesity. Diabetes. 2007 ; 56 (6). 1655-1661
6. Wurm S, Neumeier M, Weigert J, Schaffler A, Buechler C. Plasma levels of leptin, omentin, collagenous repeat-containing sequence of 26-kDa protein (CORS-26) and adiponectin before and after oral glucose uptake in slim adults. Cardiovasc Diabetol. 2007 ; 6 (1). 7
7. El-Mesallamy HO, El-Derany MO, Hamdy NM. Serum omentin-1 and chemerin levels are interrelated in patients with type 2 diabetes mellitus with or without ischaemic heart disease. Diabet Med. 2011 ; 28 (10). 1194-200
8. Yoo HJ, Hwang SY, Hong HC, et al. Association of circulating omentin-1 level with arterial stiffness and carotid plaque in type 2 diabetes. Cardiovasc Diabetol. 2011 ; 10: 103
9. Shibata R, Ouchi N, Kikuchi R, et al. Circulating omentin is associated with coronary artery disease in men. Atherosclerosis. 2011 ; 219 (2). 811-814
10. Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the syntax study. Eurointervention. 2009 ; 5 (1). 50-56
11. Attie AD, Scherer PE. Adipocyte metabolism and obesity. J Lipid Res. 2009 ; 50 (suppl). S395 - S399
12. De Clercq V, Taylor C, Zahradka P. Adipose tissue: the link between obesity and cardiovascular disease. Cardiovasc Hematol Disord Drug Targets. 2008 ; 8 (3). 228-237
13. Rajala MW, Scherer PE. Minireview: the adipocyte at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology. 2003 ; 144 (9). 3765-3773
14. Zhou JY, Chan L, Zhou SW. Omentin: linking metabolic syndrome and cardiovascular disease [published online June 22, 2012]. Curr Vasc Pharmacol. 2012 ;:
15. Sahin O, Akpek M, Elcik D, et al. Bilirubin levels and the burden of coronary atherosclerosis in patients with STEMI. Angiology. 2013 ; 64 (3). 200-204
16. Yang R-Z, Lee M-J, Hu H, et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab. 2006 ; 290 (6). 1253-1261
17. Schäffler A, Zeitoun M, Wobser H, Buechler C, Aslanidis C, Herfarth H. Frequency and significance of the novel single nucleotide missense polymorphism Val109Asp in the human gene encoding omentin in caucasian patients with type 2 diabetes mellitus or chronic inflammatory bowel diseases. Cardiovasc Diabetol. 2007 ; 6: 3
18. Senolt L, Polanská M, Filková M, et al. Vaspin and omentin: new adipokines differentially regulated at the site of inflammation in rheumatoid arthritis. Ann Rheum Dis. 2010 ; 69 (7). 1410-1411
19. Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun. 2011 ; 408 (2). 339-343